Jci_page_head_homepage_01 Jci_page_head_homepage_02
Takaaki Senbonmatsu, Sahoko Ichihara, Edward Price, F. Andrew Gaffney, Tadashi Inagami
Published in Volume 106, Issue 3
J Clin Invest. 2000; 106(3):R25 doi:10.1172/JCI10037
Abstract | Full text | PDF
Citation information

Total citations by year in CrossRef

Year: 2012 2011 2010 2009 2008 2007 2005 2004 2003 2002 2001 Total
Citations: 3 1 8 2 3 5 4 3 7 5 3 44

Citations to this article in CrossRef (44)

Title and authors Publication Year
Angiotensin II type 2 receptor agonists: where should they be applied?
Koen Verdonk, A H Jan Danser, Joep H M van Esch
Expert Opin. Investig. Drugs 2012
Angiotensin II Type-1 Receptor-JAK/STAT Pathway Mediates the Induction of Visfatin in Angiotensin II-Induced Cardiomyocyte Hypertrophy :
Liang Chang, Rong Yang, Mei Wang, Jinming Liu, Yaling Wang, Hui Zhang, Yongjun Li
The American Journal of the Medical Sciences 2012
Angiotensin II and oxidative stress in the failing heart
Daniela K Zablocki, Junichi Sadoshima
Antioxidant Redox Signal 2012
Angiotensin type 2 receptor in hypertensive cardiovascular disease
Carmine Savoia, Michela DʼAgostino, Francesco Lauri, Massimo Volpe
Current Opinion in Nephrology and Hypertension 2011
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
Bianca C. Bernardo, Kate L. Weeks, Lynette Pretorius, Julie R. McMullen
Pharmacology & Therapeutics 2010
Mast cell chymase limits the cardiac efficacy of Ang I–converting enzyme inhibitor therapy in rodents
Chih-Chang Wei, Naoki Hase, Yukiko Inoue, Eddie W. Bradley, Eiji Yahiro, Ming Li, Nawazish Naqvi, Pamela C. Powell, Ke Shi, Yoshimasa Takahashi, Keijiro Saku, Hidenori Urata, Louis J. Dell’Italia, Ahsan Husain
J. Clin. Invest. 2010
The angiotensin AT2 receptor in left ventricular hypertrophy
U Muscha Steckelings, Robert E Widdop, Ludovit Paulis, Thomas Unger
Journal of Hypertension 2010
Vasodilator therapy with hydralazine induces angiotensin AT receptor-mediated cardiomyocyte growth in mice lacking guanylyl cyclase-A.
Y Li, Y Saito, K Kuwahara, X Rong, I Kishimoto, M Harada, M Horiuchi, M Murray, K Nakao
British Journal of Pharmacology 2010
Blockage of Angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation
M. S. Carneiro-Ramos, G. P. Diniz, A. P. Nadu, J. Almeida, R. L. P. Vieira, R. A. S. Santos, M. L. M. Barreto-Chaves
Basic Res Cardiol 2010
Role of the angiotensin II type 2 receptor gene (+1675G/A) polymorphism on left ventricular hypertrophy and geometry in treated hypertensive patients
Matthias Huber, Heinz Völler, Stefanie Jakob, Rona Reibis, Van Do, Juliane Bolbrinker, Irina Zergibel, Roland E Schmieder, Andras Treszl, Karl Wegscheider, Reinhold Kreutz
Journal of Hypertension 2010